Pfizer became the first company in invoices while Daewon Pharm recorded 20% up

Based on its first generics and advanced drugs, a mid-sized company, Daewon Pharm, was the most notable company among the 30 companies in performance.

Last year, companies, such as Yuhan Corporation (excluding introduced products), Bayer Korea and SK Chemical, have suffered from 10% decreased invoices compared to the year before.

Additionally, Novartis, a former leading company, has fell down...